Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study

Details 詳細情報について

• CRID

  1360572092858196736

• DOI

  10.1007/s10147-020-01797-5

• ISSN

  14377772

  13419625

• Web Site

  https://link.springer.com/content/pdf/10.1007/s10147-020-01797-5.pdf

  https://link.springer.com/article/10.1007/s10147-020-01797-5/fulltext.html

• Data Source

  • Crossref
  • KAKEN